World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
19259
World Ranking
16330
National Ranking
8213

Overview

E. Steve Woodle is affiliated with the University of Cincinnati Medical Center in the United States, contributing to the field of medicine with a focus on transplantation and immunology. Their research output spans a range of topics including renal transplantation outcomes, immunology relating to T-cell and B-cell functions, and infectious diseases such as hepatitis C virus and SARS-CoV-2.

Woodle's recent publications include:

  • "Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement," 2020, American Journal of Transplantation
  • "Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement," 2020, American Journal of Transplantation
  • "Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection," 2020, Journal of the American Society of Nephrology
  • "Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins," 2020, Transplantation
  • "Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients," 2021, JAMA Surgery

Their work has appeared most frequently in the following publication venues:

  • American Journal of Transplantation (13 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (9 publications)
  • Transplantation (6 publications)
  • Journal of the American Society of Nephrology (5 publications)
  • Transplantation Direct (4 publications)

Woodle's research topics cover a broad spectrum related to transplantation and immunology, including:

  • Renal Transplantation Outcomes and Treatments
  • T-cell and B-cell Immunology
  • SARS-CoV-2 and COVID-19 Research
  • Systemic Lupus Erythematosus Research
  • Renal Diseases and Glomerulopathies
  • Hepatitis C virus research
  • Cytomegalovirus and herpesvirus research

Their main fields and subfields of study consist of:

  • Medicine
  • Immunology
  • Transplantation
  • Infectious Diseases
  • Hepatology
  • Oncology

Frequent co-authors collaborating with Woodle include:

  • David A. Hildeman
  • Rita R. Alloway
  • Adele R. Shields
  • Krishna M. Roskin
  • Jonathan S. Maltzman

Best Publications

  • The immune cell landscape in kidneys of patients with lupus nephritis

    Arnon Arazi;Deepak A Rao;Celine C Berthier;Anne Davidson

  • Malignancy after transplantation.

    Joseph F Buell;Thomas G Gross;E Steve Woodle

  • A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

    E. Steve Woodle;M. Roy First;John Pirsch;Fuad Shihab

  • Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

    Matthew J. Everly;Jason J. Everly;Brian Susskind;Paul Brailey

  • Alemtuzumab Induction in Renal Transplantation

    Michael J. Hanaway;E. Steve Woodle;Shamkant Mulgaonkar;V. Ram Peddi

  • Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

    Osama O. Gaber;M. Roy First;Raymond J. Tesi;Robert S. Gaston

  • Ethics of a paired-kidney-exchange program.

    L F Ross;D T Rubin;M Siegler;M A Josephson

  • De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.

    Yun Miao;Jason J. Everly;Thomas G. Gross;Amit D. Tevar

  • Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

    M. J. Everly;J. J. Everly;L. J. Arend;P. Brailey

  • Complications in 100 living-liver donors.

    Hani Grewal;J. Thistlethwaite;George Loss;Jonathan Fisher

  • The role of donor-specific HLA alloantibodies in liver transplantation.

    J.G. O'Leary;A.J. Demetris;L.S. Friedman;Howard Gebel

  • Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection

    Woodle Es;Xu D;Zivin Ra;Auger J

  • Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

    R. Carlin Walsh;Jason J. Everly;Paul Brailey;Adele H. Rike

  • Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.

    R Ferguson;J Grinyo;Francesco Vincenti;D Kaufman

  • Donor-Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk

    M. A. Nalesnik;E. S. Woodle;J. M. Dimaio;B. Vasudev

  • An initial experience and evolution of laparoscopic hepatic resectional surgery

    Joseph F. Buell;Mark J. Thomas;Travis C. Doty;Keith S. Gersin

  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study.

    R. A. Montgomery;B. J. Orandi;L. Racusen;A. M. Jackson

  • Portal vein thrombosis and stenosis in pediatric liver transplantation

    J M Millis;D S Seaman;J B Piper;E M Alonso

  • Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients.

    J. Millis;David Cronin;Lynda Brady;Kenneth Newell

  • Immunosuppression and Merkel cell cancer.

    Joseph F Buell;J Trofe;M J Hanaway;T M Beebe

Frequent Co-Authors

David A. Hildeman
David A. Hildeman Cincinnati Children's Hospital Medical Center
Nir Hacohen
Nir Hacohen Harvard University
Michael B. Brenner
Michael B. Brenner Harvard Medical School
Kenneth E. Sherman
Kenneth E. Sherman University of Cincinnati Medical Center
Betty Diamond
Betty Diamond Feinstein Institute for Medical Research
Anne Davidson
Anne Davidson Feinstein Institute for Medical Research
David Wofsy
David Wofsy University of California, San Francisco
James A. Lederer
James A. Lederer Brigham and Women's Hospital
Howard M. Gebel
Howard M. Gebel Emory University
Jennifer H. Anolik
Jennifer H. Anolik University of Rochester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career pathways in medicine doesn't always require a traditional four-year medical degree. Many students are now turning to online programs that offer flexibility and diverse options. For example, direct entry online MSN programs are available for non-nurses who want to quickly transition into advanced nursing roles without earning a BSN first.

If you’re looking to enter the nursing field with fewer obstacles, some nursing programs with high acceptance rates make it more accessible for students to start their journey. For those interested in administrative healthcare roles, several medical billing and coding online schools that accept financial aid offer accredited options that can be completed remotely.

Additionally, students who wish to become Licensed Practical Nurses (LPNs) can take advantage of an lpn program without teas test requirement, streamlining admissions. These online and alternative pathways provide multiple entry points to rewarding careers in healthcare, tailored to a variety of needs and backgrounds.

Best Scientists Citing E. Steve Woodle

Trending Scientists